AirSculpt Technologies Inc. (AIRS) is a Medical/Nursing Services company listed on NASDAQ. In the last 30 days Quantisnow tracked 3 wire items for AIRS, including 1 press release or news item, 1 analyst rating and 1 earnings update. The most recent was published Nov 2, 2026.
AIRS rankings
Financial highlights
Full financials- Revenue, TTM
- $150.72M
- Revenue growth
- -8.7%
- Net income, TTM
- -$11.74M
- Net margin
- -7.8%
- Free cash flow, TTM
- $760.0K
- Cash
- $18.82M
For the twelve months ended Jun 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks13+100%
2026-05-102026-11-01
Mix790d
- Earnings2(29%)
- SEC Filings2(29%)
- Other2(29%)
- Analyst1(14%)
Latest news
25 items- PRAirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for Third Quarter Fiscal 2026 ResultsMIAMI BEACH, Fla., Nov. 02, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt" or the "Company") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report third quarter 2026 financial results before market open on Friday, November 6, 2026, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The earnings conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13763463 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor re
- ANALYSTLake Street initiated coverage on AirSculpt Technologies with a new price targetLake Street initiated coverage of AirSculpt Technologies with a rating of Buy and set a new price target of $3.00
- SECAmendment: SEC Form SCHEDULE 13G/A filed by AirSculpt Technologies Inc.SCHEDULE 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by AirSculpt Technologies Inc.SCHEDULE 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)
- SECSEC Form 10-Q filed by AirSculpt Technologies Inc.10-Q - Airsculpt Technologies, Inc. (0001870940) (Filer)
- SECAirSculpt Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)
- PRAirSculpt Technologies Reports Second Quarter Fiscal 2026 ResultsMIAMI BEACH, Fla., Aug. 10, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the second quarter ended June 30, 2026. Yogi Jashnani, Chief Executive Officer, stated: "In the second quarter, we advanced our key priorities — delivering our second quarter of stability. During the quarter, we stepped up our investment in marketing and advanced our plans to introduce new, sought-after procedures including entering an exclusive partnership with AlloClae that expands our treatment offering and enhances our body contouring platform." "We enter the second half of
- PRAirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for Second Quarter Fiscal 2026 ResultsMIAMI BEACH, Fla., Aug. 03, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt" or the "Company") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report second quarter 2026 financial results before market open on Monday, August 10, 2026, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The earnings conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13761751 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor re
- PRAirSculpt Technologies Announces Participation in Upcoming Investor ConferencesMIAMI BEACH, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt" or the "Company") (NASDAQ:AIRS), an industry leader and provider of premium body contouring procedures, today announced that the Company will participate in upcoming investor conferences. On June 3, 2026, the Company will participate in the TD Cowen 10th Annual Future of the Consumer Conference being held at the Lotte New York Palace in New York City. Management will host a fireside chat presentation at 11:45 a.m. Eastern Time and hold investor meetings throughout the day. On June 9, 2026, the Company will participate in the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference being h
- INSIDERDirector Feinstein Adam T disposed of 5,169,820 shares (SEC Form 4)4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
- INSIDERDirector Higgins Kenneth was granted 100,286 shares, increasing direct ownership by 58% to 274,066 units (SEC Form 4)4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
- INSIDERDirector Aaron Thomas J was granted 100,286 shares, increasing direct ownership by 57% to 276,866 units (SEC Form 4)4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
- INSIDERDirector Chu Caroline was granted 100,286 shares, increasing direct ownership by 57% to 277,066 units (SEC Form 4)4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
- SECSEC Form 10-Q filed by AirSculpt Technologies Inc.10-Q - Airsculpt Technologies, Inc. (0001870940) (Filer)
- SECAirSculpt Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)
- PRAirSculpt Technologies Reports First Quarter Fiscal 2026 ResultsMIAMI BEACH, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2026. Yogi Jashnani, Chief Executive Officer, stated: "We had a solid start to the year delivering stabilization in revenue, positive same center sales, and a strengthened balance sheet in the first quarter. Our performance marks a key turning point for AirSculpt - the culmination of our transformational work in 2025 has given us a durable business model and a solid foundation to advance our strategy to achieve sustained long term profitable grow
- PRAirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 ResultsMIAMI BEACH, Fla., May 01, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt" or the "Company") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report first quarter 2026 financial results before market open on Friday, May 8, 2026, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The earnings conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13760143 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relation
- INSIDERSEC Form 4 filed by Chernett Jorey4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
- SECSEC Form DEF 14A filed by AirSculpt Technologies Inc.DEF 14A - Airsculpt Technologies, Inc. (0001870940) (Filer)
- INSIDERSEC Form 4 filed by Chernett Jorey4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
- INSIDERSEC Form 4 filed by Jashnani Yogesh4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
- INSIDERSEC Form 4 filed by Arthur Michael J4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
- INSIDERSEC Form 4 filed by Wadman Brent R4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
- INSIDERSEC Form 4 filed by Chernett Jorey4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
- INSIDERSEC Form 4 filed by Chernett Jorey4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
AIRS FAQ
11 questionsWhat does AirSculpt Technologies Inc. do?
AirSculpt Technologies, Inc. focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a...What is the latest news on AIRS?
In the last 30 days Quantisnow tracked 3 wire items for AIRS: 1 press release or news item, 1 analyst rating and 1 earnings update. The most recent was published on November 2, 2026.What is AIRS revenue?
AirSculpt Technologies Inc. (AIRS) reported $150.72M of revenue for the twelve months ended Jun 30, 2026. That is down 8.7% from the year before. Revenue for fiscal 2025 was $151.82M.Is AIRS profitable?
No. AirSculpt Technologies Inc. reported a net loss of $11.74M for the twelve months ended Jun 30, 2026.How much cash and debt does AIRS have?
AirSculpt Technologies Inc. reported $18.82M in cash and cash equivalents and $43.57M of debt on its most recent balance sheet in SEC filings.Where does AIRS stock trade?
AirSculpt Technologies Inc. (AIRS) is listed on NASDAQ.What sector and industry is AIRS in?
AirSculpt Technologies Inc. operates in the Health Care sector, Medical/Nursing Services industry.When did AirSculpt Technologies Inc. go public?
AirSculpt Technologies Inc. (AIRS) completed its IPO in 2021.What are analysts saying about AIRS?
Across the last 8 analyst actions on AirSculpt Technologies Inc., there were 0 upgrades and 3 downgrades. The most recent action was from Lake Street: Buy with a $3.00 price target on 2026-10-29.What companies are similar to AIRS?
Notable peers in the same industry include BTSG (BrightSpring Health Services Inc.), CHE (Chemed Corp), HIMS (Hims & Hers Health Inc.), LFST (LifeStance Health Group Inc.), OPCH (Option Care Health Inc.). Compare AIRS side-by-side with any of them on Quantisnow.How can I track AIRS on Quantisnow?
Quantisnow aggregates AirSculpt Technologies Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AIRS to receive live email and push alerts on every new disclosure.